Associated tags: Parenteral Drug Association, PDA, U.S. FDA, Risk management, Cryptocurrency
Locations: SWITZERLAND, SINGAPORE, CHINA, BANGLADESH, INDIA, UNITED ARAB EMIRATES, BATTELLE, MALAYSIA, APAC, SPAIN, ASIA PACIFIC, NETHERLANDS, EUROPE, UNITED STATES, PORTUGAL, NORTH AMERICA, CALIFORNIA, RARE, EU
Software,
Research,
Other Health,
Pharmaceutical,
Electronic Design Automation,
Data Management,
Technology,
Medical Devices,
Health Technology,
Science,
Biotechnology,
Health,
Other Science,
Risk management,
City,
Product management,
CPV,
CSA,
Ecosystem,
Pharma The conference starts June 17th and concludes June 19th and will host industry experts, customers, partners, and ValGenesis subject matter experts sharing their immense knowledge through interactive sessions, roundtable discussions, product trainings, and professional networking.
Key Points:
- The conference starts June 17th and concludes June 19th and will host industry experts, customers, partners, and ValGenesis subject matter experts sharing their immense knowledge through interactive sessions, roundtable discussions, product trainings, and professional networking.
- ValGenesis will also host a special tour of Sintra, the beautiful, historic area of palaces and vistas just outside Lisbon.
- Hosting ValConnect 2024 Europe in Lisbon presents an ideal opportunity for the company’s rich ecosystem to connect, learn, and innovate in one of the most beautiful cities on the continent.
- Registration for ValConnect is free for all ValGenesis customers and partners.
Technology,
Medical Devices,
Health Technology,
Software,
Biotechnology,
General Health,
Pharmaceutical,
Health,
Science,
Other Science,
FDA,
Partner,
Safety,
Partnership,
ISO,
Drug development,
GMP,
ISPE,
Cryptocurrency Adryan is an internationally operating services group, active throughout western Europe and involved in various associations, such as the ISPE, to develop a sustainable future for life sciences.
Key Points:
- Adryan is an internationally operating services group, active throughout western Europe and involved in various associations, such as the ISPE, to develop a sustainable future for life sciences.
- ValGenesis and Adryan have strengthened their capabilities to assist life sciences companies meet stringent ISO, FDA, and EU regulatory requirements for quality and safety in drug development and manufacturing.
- “Adryan is a technology innovator contributing to the development of various markets in the life sciences industry in Europe.
- We are thrilled to partner with market leader ValGenesis, enabling us to provide our network with the best digital validation solutions."
Data Management,
Technology,
Health,
General Health,
Pharmaceutical,
Health Technology,
Other Science,
Research,
Software,
Science,
Electronic Design Automation,
Partner,
Risk,
Pharma,
Partnership,
Business process management,
Drug development,
GMP,
Cryptocurrency ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and DynaCompliance Pvt.
Key Points:
- ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and DynaCompliance Pvt.
- Ltd., a compliance and validation solutions company, have partnered to strategically advance the adoption of ValGenesis’ industry-leading suite of digital validation solutions for life sciences companies across India and the US.
- DynaCompliance helps life sciences companies integrate the latest digital technologies and data-driven approaches into drug development, manufacturing, and validation processes, through comprehensive compliance and validation solutions.
- “We are excited that DynaCompliance has decided to partner with ValGenesis as their preferred provider of solutions for life sciences companies to achieve their Pharma 4.0 digital transformation objectives.”
“We are thrilled to partner with ValGenesis, a recognized leader in digital validation solutions,” says Sheetal Patel, Managing Director and Founder of DynaCompliance Pvt.
Software,
Biotechnology,
Pharmaceutical,
Health,
Data Management,
Infectious Diseases,
Health Technology,
Technology,
Knowledge management,
Risk management,
Neuropsychiatry,
Neurology,
Workflow ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a leading global biotechnology company selected ValGenesis iRisk to digitalize the quality risk management processes across its manufacturing sites.
Key Points:
- ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a leading global biotechnology company selected ValGenesis iRisk to digitalize the quality risk management processes across its manufacturing sites.
- A pioneer in scientific research for complex and devastating diseases, the company is advancing a pipeline of potential critical drug therapies across neurology, neuropsychiatry, specialized immunology, and rare diseases.
- Hearing about iRisk from a ValGenesis customer, the company approached ValGenesis to implement iRisk at its headquarters in the United States, to support its small molecule drug product development team in the digitalization of its quality risk management processes.
- “Having the best risk management tools gathered collectively under ValGenesis iRisk is a game changer for customers.
Software,
Professional Services,
Business,
Data Management,
Start-Up,
Apps,
Applications,
Technology,
Science,
Engineering,
Consulting,
Manufacturing,
Other Science,
Partner,
Partnership,
GMP,
Multimedia,
ICT,
Cryptocurrency ValGenesis and Contrader offer innovative, end-to-end digital solutions that help life sciences companies meet stringent regulatory requirements on their Industry 4.0 journey.
Key Points:
- ValGenesis and Contrader offer innovative, end-to-end digital solutions that help life sciences companies meet stringent regulatory requirements on their Industry 4.0 journey.
- Contrader will implement and manage ValGenesis’ digital validation tools, including the industry-leading ValGenesis VLMS and VLMS Express , a simplified cloud-based digital validation solution for startups and midsized companies.
- “Contrader is a key technology enabler and a reliable partner for the entire R&D platform.
- Combining Contrader’s expertise with ValGenesis' cutting-edge offerings positions us well to navigate and overcome the complexities of digital transformation.
Electronic Design Automation,
Data Management,
Technology,
Consulting,
Business,
Professional Services,
General Health,
Artificial Intelligence,
Science,
Software,
Networks,
Other Science,
Internet,
Health,
Research,
Automation,
Partner,
Partnership,
AI,
Multimedia,
Cryptocurrency Billennium will implement and manage the entire range of ValGenesis products including ValGenesis VLMS , the industry standard digital validation platform for life sciences worldwide.
Key Points:
- Billennium will implement and manage the entire range of ValGenesis products including ValGenesis VLMS , the industry standard digital validation platform for life sciences worldwide.
- “ValGenesis and Billennium share a common vision of combining passion and technological expertise to change the life sciences landscape,” says Bo Olsen, ValGenesis’ SVP of Partners.
- This partnership allows us to strategically expand our offerings and assist in driving IT projects in the life sciences industry.
- We are thrilled to work hand in hand with ValGenesis to achieve these goals," says Aleksandra Żamojć, Partner Sales Manager of Billennium.
SANTA CLARA, Calif., March 12, 2024 /PRNewswire/ -- ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a Japanese multinational biopharmaceutical company selected ValGenesis iRisk for implementing the ICH Q14 framework on Process Analytical Technology (PAT) analytical methods across its global manufacturing sites.
Key Points:
- SANTA CLARA, Calif., March 12, 2024 /PRNewswire/ -- ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), today announced that a Japanese multinational biopharmaceutical company selected ValGenesis iRisk for implementing the ICH Q14 framework on Process Analytical Technology (PAT) analytical methods across its global manufacturing sites.
- Already aware of ValGenesis' experience helping customers implement PAT tools, the company approached ValGenesis with a requirement to implement a structured framework covering the ICH Q14 guideline on Analytical Method Development, specifically for PAT.
- ValGenesis Consulting will lead the implementation of the ICH Q14 framework via a thorough assessment of the customer's current analytical method development practices across its sites, propose a framework for ICH Q14 adoption using ValGenesis iRisk , build the case for the customer's product in ValGenesis iRisk, and train a group of key users within their global MSAT team on the utilization of the framework on ValGenesis iRisk with sandbox access.
- With ValGenesis iRisk, our customer is assured of a risk-based Quality by Design (QbD) approach to highly compliant and cost-effective manufacturing."
In the consultancy business for over 20 years, CSols is well-known and respected in the U.S. and Canada in a variety of scientific industries.
Key Points:
- In the consultancy business for over 20 years, CSols is well-known and respected in the U.S. and Canada in a variety of scientific industries.
- Eighty percent of CSols's current work supports new drug development in life sciences and the manufacturing of existing medicines through the application of laboratory informatics.
- "We are excited about our partnership with CSols and their excellent track record in informatics.
- We are pleased to partner with ValGenesis to bring our expertise to a greater range of life science companies.
Retrieved on:
Tuesday, February 13, 2024
SANTA CLARA, Calif., Feb. 13, 2024 /PRNewswire/ -- ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and RxCloud, a specialized consulting and systems integration organization, have entered into a strategic partnership to address quality assurance and compliance challenges in life sciences.
Key Points:
- SANTA CLARA, Calif., Feb. 13, 2024 /PRNewswire/ -- ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and RxCloud, a specialized consulting and systems integration organization, have entered into a strategic partnership to address quality assurance and compliance challenges in life sciences.
- RxCloud provides a suite of accelerators and frameworks to help companies attain their business goals quicker and more efficiently.
- "ValGenesis and RxCloud will enhance processes, procedures, technologies, and environments to help life sciences companies get their products to market more safely and efficiently."
- We are excited about this strategic partnership with ValGenesis!"
Retrieved on:
Tuesday, February 6, 2024
Amaris Consulting provides high value-added technology services in the digital and information systems, telecommunications, life sciences and engineering fields for over 1,000 clients across the globe.
Key Points:
- Amaris Consulting provides high value-added technology services in the digital and information systems, telecommunications, life sciences and engineering fields for over 1,000 clients across the globe.
- "Our partnership with Amaris Consulting has materialized as life sciences companies are looking for robust and truly risk-based digitized validation solutions," says Bo Olsen, ValGenesis' SVP of Partners.
- "This partnership with ValGenesis is a pivotal step for Amaris Consulting, as it allows us to integrate advanced digital validation solutions into our client-focused offerings.
- It underscores our commitment to guiding clients through their tech transformation journeys, specifically addressing the unique needs of the healthcare sector in the EU and LATAM," says Roman Lauzin, Director, Benelux & Nordics, at Amaris Consulting.
